Home Medicine Mutations in BTD gene causing biotinidase deficiency: a regional report
Article
Licensed
Unlicensed Requires Authentication

Mutations in BTD gene causing biotinidase deficiency: a regional report

  • Çiğdem Seher Kasapkara EMAIL logo , Melek Akar , Mehmet Nuri Özbek , Heybet Tüzün , Bedri Aldudak , Rıza Taner Baran and Tijen Tanyalçın
Published/Copyright: November 25, 2014

Abstract

Biotinidase deficiency is an autosomal recessive inborn error of biotin metabolism. Children with biotinidase deficiency cannot cleave biocytin and, therefore, cannot recycle biotin. Untreated individuals become secondarily biotin deficient, which in turn results in decreased activities of the biotin-dependent carboxylases and the subsequent accumulation of toxic metabolites causing clinical symptoms. Biotinidase deficiency is characterized by neurological, cutaneous manifestations and metabolic abnormalities. The worldwide incidence of profound biotinidase deficiency has been estimated at 1:112,271. The human biotinidase gene is located on chromosome 3p25 and consists of four exons with a total length of 1629 base pairs. To date, more than 100 mutations in the biotinidase gene known to cause biotinidase deficiency have been reported. The vast majority of mutations are homozygous or compound heterozygous. Finding known mutations can be correlated with the biochemical enzymatic results. This report summarizes the demographic features of patients identified as biotinidase deficient from August of 2012 through August of 2013 and mutation analysis results for 20 cases in the southeast region of Turkey.


Corresponding author: Dr. Çiğdem Seher Kasapkara, Department of Pediatric Metabolism and Nutrition, Dr. Sami Ulus Maternity and Children Research and Training Hospital, Ankara, Turkey, E-mail:

References

1. Sivri HS, Genç GA, Tokatli A, Dursun A, Coşkun T, et al. Hearing loss in biotinidase deficiency: genotype-phenotype correlation. J Pediatr 2007;150:439–42. Erratum in: J Pediatr 2007;151:222.Search in Google Scholar

2. Milánkovics I, Kámory E, Csókay B, Fodor F, Somogyi C, et al. Mutations causing biotinidase deficiency in children ascertained by newborn screening in Western Hungary. Mol Genet Metab 2007;90:345–8.10.1016/j.ymgme.2006.11.005Search in Google Scholar

3. Neto EC, Schulte J, Rubim R, Lewis E, DeMari J, et al. Newborn screening for biotinidase deficiency in Brazil: biochemical and molecular characterizations. Braz J Med Biol Res 2004;37:295–9.10.1590/S0100-879X2004000300001Search in Google Scholar

4. Dobrowolski SF, Angeletti J, Banas RA, Naylor EW. Real time PCR assays to detect common mutations in the biotinidase gene and application of mutational analysis to newborn screening for biotinidase deficiency. Mol Genet Metab 2003;78:100–7.10.1016/S1096-7192(02)00231-7Search in Google Scholar

5. Wolf B, Jensen K, Hüner G, Demirkol M, Baykal T, et al. Seventeen novel mutations that cause profound biotinidase deficiency. Mol Genet Metab 2002;77:108–11.10.1016/S1096-7192(02)00149-XSearch in Google Scholar

6. Wolf B. Children with profound biotinidase deficiency should be treated with biotin regardless of their residual enzyme activity or genotype. Eur J Pediatr 2002;161:167–8; author reply 169.10.1007/s00431-001-0902-8Search in Google Scholar

7. Pettit DA, Amador PS, Wolf B. The quantitation of biotinidase activity in dried blood spots using microtiter transfer plates: identification of biotinidase-deficient and heterozygous individuals. Anal Biochem 1989;179:371–4.10.1016/0003-2697(89)90147-4Search in Google Scholar

8. Hymes J, Stanley CM, Wolf B. Mutations in BTD causing biotinidase deficiency. Hum Mutat 2001;18:375–81.10.1002/humu.1208Search in Google Scholar PubMed

9. Blanton SH, Pandya A, Landa BL, Javaheri R, Xia X, et al. Fine mapping of the human biotinidase gene and haplotype analysis of five common mutations. Hum Hered 2000;50:102–11.10.1159/000022897Search in Google Scholar PubMed

10. Pomponio RJ, Hymes J, Reynolds TR, Meyers GA, Fleischhauer K, et al. Mutations in the human biotinidase gene that cause profound biotinidase deficiency in symptomatic children: molecular, biochemical, and clinical analysis. Pediatr Res 1997;42:840–8.10.1203/00006450-199712000-00020Search in Google Scholar PubMed

11. Pomponio RJ, Reynolds TR, Mandel H, Admoni O, Melone PD, et al. Profound biotinidase deficiency caused by a point mutation that creates a downstream cryptic 3′ splice acceptor site within an exon of the human biotinidase gene. Hum Mol Genet 1997;6:739–45.10.1093/hmg/6.5.739Search in Google Scholar PubMed

12. Pomponio RJ, Narasimhan V, Reynolds TR, Buck GA, Povirk LF, et al. Deletion/insertion mutation that causes biotinidase deficiency may result from the formation of a quasipalindromic structure. Hum Mol Genet 1996;5:1657–61.10.1093/hmg/5.10.1657Search in Google Scholar PubMed

13. Procter M, Wolf B, Crockett DK, Mao R. The Biotinidase Gene Variants Registry: a paradigm public database. G3: Genes | Genomes | Genetics 2013;3. Published online at April 2013. doi:pii: g3.113.005835v1. 10.1534/g3.113.005835.10.1534/g3.113.005835Search in Google Scholar PubMed PubMed Central

14. Iqbal F, Item CB, Vilaseca MA, Jalan A, Mühl A, et al. The identification of novel mutations in the biotinidase gene using denaturing high pressure liquid chromatography (dHPLC). Mol Genet Metab 2010;100:42–5.10.1016/j.ymgme.2009.12.016Search in Google Scholar PubMed

15. Chedrawi AK, Ali A, Al Hassnan ZN, Faiyaz-Ul-Haque M, Wolf B. Profound biotinidase deficiency in a child with predominantly spinal cord disease. J Child Neurol 2008;23:1043–8.10.1177/0883073808318062Search in Google Scholar PubMed

16. Thodi G, Schulpis KH, Molou E, Georgiou V, Loukas YL, et al. High incidence of partial biotinidase deficiency cases in newborns of Greek origin. Gene 2013;524:361–2.10.1016/j.gene.2013.04.059Search in Google Scholar PubMed

17. Tiar A, Mekki A, Nagara M, Rhouma FB, Messaoud O, et al. Biotinidase deficiency: novel mutations in Algerian patients. Gene. 2014;536(1):193–6. doi:pii: S0378-1119(13)00185-6. 10.1016/j.gene.2013.02.011.10.1016/j.gene.2013.02.011Search in Google Scholar PubMed

18. Afroze B, Wasay M. Biotinidase deficiency in Pakistani children; what needs to be known and done. J Pak Med Assoc 2012;62:312–3.Search in Google Scholar

19. Cowan TM, Kazerouni NN, Dharajiya N, Lorey F, Roberson M, et al. Increased incidence of profound biotinidase deficiency among Hispanic newborns in California. Mol Genet Metab 2012;106:485–7.10.1016/j.ymgme.2012.05.017Search in Google Scholar PubMed

20. Zempleni J, Kuroishi T. Biotin. Adv Nutr 2012;3:213–4.10.3945/an.111.001305Search in Google Scholar PubMed PubMed Central

21. Hayati AA, Wan-Hitam WH, Cheong MT, Yunus R, Shatriah I. Optic neuritis in a child with biotinidase deficiency: case report and literature review. Clin Ophthalmol 2012;6:389–95.Search in Google Scholar

22. Küry S, Ramaekers V, Bézieau S, Wolf B. Clinical utility gene card for: biotinidase deficiency. Eur J Hum Genet 2012;20. doi: 10.1038/ejhg.2012.28.10.1038/ejhg.2012.28Search in Google Scholar PubMed PubMed Central

Received: 2014-2-12
Accepted: 2014-10-22
Published Online: 2014-11-25
Published in Print: 2015-3-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Highlight: Diabetes
  3. Diabetes mellitus in children and adolescents – a global epidemic which has become neglected
  4. Maturity-onset diabetes of the young (MODY): an update
  5. Relationship of plasma level of chemerin and vaspin to early atherosclerotic changes and cardiac autonomic neuropathy in adolescent type 1 diabetic patients
  6. How does autoimmune thyroiditis in children with type 1 diabetes mellitus influence glycemic control, lipid profile and thyroid volume?
  7. Profile of mood states in adult type 1 diabetes mellitus men and women with disease onset in childhood and in adulthood
  8. Evaluation of fetuin-A and carotid intima-media thickness in adolescent type 1 diabetic patients
  9. An increasing incidence of type 1 diabetes mellitus in Romanian children aged 0 to 17 years
  10. Resistin and right ventricular function in children with recently diagnosed type-1 diabetes mellitus: a case control study
  11. Assessment of human cartilage glycoprotein 39 (YKL-40), preptin, and nitric oxide in adolescent patients with type 1 diabetes and its relation to cardiorenal affection
  12. The effect of a home-based strength training program on type 2 diabetes risk in obese Latino boys
  13. From cerebral salt wasting to diabetes insipidus with adipsia: case report of a child with craniopharyngioma
  14. Three years of liraglutide treatment offers continuously optimal glycemic control in a pediatric patient with maturity-onset diabetes of the young type 3
  15. Diabetic euglycemic ketoacidosis in newly diagnosed type 1 diabetes mellitus during Ramadan fasting
  16. Transient neonatal hyperinsulinism with adaptation disorders: a report of three cases
  17. Acute mononeuropathy in a child with newly diagnosed type 1 diabetes mellitus
  18. Alternating hypoglycemia and hyperglycemia in a toddler with a homozygous p.R1419H ABCC8 mutation: an unusual clinical picture
  19. Cognitive functioning, metabolic control, and treatment type in youth with type 1 diabetes
  20. Images in pediatric endocrinology
  21. Benefit of testosterone in pediatric genital trauma
  22. Original articles
  23. Attenuated salivary cortisol response after exercise test in children with asthma
  24. Reliability of pubertal maturation self-assessment in a school-based survey
  25. Detection of inborn errors of metabolism using GC-MS: over 3 years of experience in southern China
  26. Assessing biological maturity: chronological age and the pubertal development scale predict free testosterone in adolescent males
  27. Evaluation of puberty by verifying spontaneous and stimulated gonadotropin values in girls
  28. Longitudinal changes in C-reactive protein, proform of eosinophil major basic protein, and pregnancy-associated plasma protein-A during weight changes in obese children
  29. Caries in adolescents in relation to their skeletal status
  30. Endothelial and metabolic disorders in adolescence: low birth weight is not an isolated risk factor
  31. Comparison of cortisol samples in the first two weeks of life in preterm infants
  32. Mutations in BTD gene causing biotinidase deficiency: a regional report
  33. Patient reports
  34. Late-onset hypercalcemia in Williams-Beuren syndrome: importance of early and frequent screening and intervention
  35. Hepatoblastoma presenting as precocious puberty: a case report
  36. Three cases of Wolfram syndrome with different clinical aspects
  37. L-asparaginase induced hypoglycemia in a case of acute lymphoblastic leukemia: a patient report
  38. Pyogenic granuloma, an unusual presentation of peripubertal vaginal bleeding. Case report and review of the literature
  39. Octreotide-associated cholestasis and hepatitis in an infant with congenital hyperinsulinism
  40. Two novel mutations in the homogentisate-1,2-dioxygenase gene identified in Chinese Han Child with Alkaptonuria
  41. Pituitary abscess in an adolescent girl: a case report and review of the literature
  42. Neonatal thyrotoxicosis with severe supraventricular tachycardia: case report and review of the literature
  43. Consumptive hypothyroidism associated with parotid infantile hemangioma
  44. Novel mutations in the SLC25A13 gene in a patient with NICCD and severe manifestations
  45. Short communications
  46. Tetrahydrobiopterin deficiency among Serbian patients presenting with hyperphenylalaninemia
Downloaded on 28.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0056/html
Scroll to top button